ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthetic Biology

Ansa raises funds to make DNA with enzymes

by Melody M. Bomgardner
September 19, 2020 | APPEARED IN VOLUME 98, ISSUE 36

 

Ansa Biotechnologies has raised $7.9 million in seed financing, bringing its funding to date to $9.2 million. The California-based company synthesizes DNA with a fully enzymatic process that it claims results in longer, higher-quality strands than DNA made with phosphoramidite chemistry, which limits assembled DNA to about 200 base pairs. Firms like Ansa and Molecular Assemblies, founded in 2013, say enzymes can make the longer DNA desired for synthetic biology and data storage.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment